Strategies & Technologies Driving Drug Discovery to Market
Subscribe to Drug Discovery & Development All

Mylan Launches Generic Felbatol Tablets

January 22, 2016 8:00 am | News | Comments

Felbamate Tablets are recommended for monotherapy or adjunctive therapy in the treatment of partial seizures. Read more...


PrEP Drugs Could Reverse HIV in U.K.

January 22, 2016 7:45 am | by London School of Hygiene & Tropical Medicine | News | Comments

Antiretroviral therapy taken as pre-exposure prophylaxis could help dramatically reduce the new HIV infection rate among men who have sex with men. Read more...


Novo Aims to be Ahead of Pharma Pack with Iran Investment

January 22, 2016 7:30 am | by Ben Hirschler and Kate Kelland, Reuters | News | Comments

Danish drugmaker Novo Nordisk, the world's top insulin supplier, expects to be ahead of the pack now nuclear sanctions are lifted in Iran. Read more...


EMA Granted Approval to 93 Drugs in 2015

January 22, 2016 7:15 am | News | Comments

The European Medicines Agency (EMA) has released an overview of its 2015 key recommendations. Read more...


The Sun Goes Down on Vitamin D

January 22, 2016 7:00 am | by Tim Spector, King's College London, The Conversation | News | Comments

Everyone loves D, the sunshine vitamin. Doctors, patients and the media have been enamored with vitamin D supplements for decades. Read more...


Blood Test May Predict If You Really Need Antibiotics

January 21, 2016 1:25 pm | by Stephanie Guzowski, Editor | News | Comments

Antibiotics are often overprescribed and misused, leading to a global threat of antibiotic resistance. But in a new study, researchers say they’re a step closer to developing a rapid blood test that distinguishes between viral and bacterial respiratory infections, which would mean more accurate antibiotic prescribing. Read more...


New Biomarkers May Influence Drug Design and Alternative Cancer Treatments, Study Shows

January 21, 2016 11:21 am | by Georgia State University | News | Comments

Researchers have discovered gene-targets (biomarkers) that may enable alternative treatments or the potential design of new drugs that target metastasis-promoting tumor genes. Read more...

Brain Scans May Identify Children Who Are Vulnerable to Depression, Before Symptoms Appear

January 21, 2016 11:11 am | by Anne Trafton, MIT News Office | News | Comments

A new brain imaging study from MIT and Harvard Medical School may lead to a screen that could identify children at high risk of developing depression later in life. Read more...


More than 1,000 Tested for Tuberculosis in Rural Alabama

January 21, 2016 10:59 am | by Philip Lucas, Associated Press | News | Comments

Tuberculosis, a global scourge, has mostly been eradicated in the United States, but minorities and poor people who lack regular health care remain vulnerable. Marion, the town where Coretta Scott King was raised, is just that kind of community: the seat of Alabama's poorest county, where 47 percent live in poverty and the per-capita annual income is just $13,000. Read more...


Alkermes Depression Drug Fails in Two Late-Stage Trials

January 21, 2016 10:31 am | by Stephanie Guzowski, Editor | News | Comments

Alkermes on Thursday said two Phase 3 studies of its drug for major depressive disorder (MDD) failed to meet their primary endpoints, sending the company’s shares down more than 30 percent in premarket trading. Read more...


Five Indicted on Charges of Stealing Pharma Information for Startup

January 21, 2016 10:21 am | by Seth Augenstein, Digital Reporter | News | Comments

Two GlaxoSmithKline scientists and three co-conspirators were indicted on charges of stealing pharmaceutical trade secrets. Read more...


Drugmakers Propose New Plan for Fighting Superbugs

January 21, 2016 9:15 am | by Ryan Bushey, Associate Editor | News | Comments

Its asking for global assistance in creating new types of antibiotics. Read more...


The Fallout from the Fatal Drug Study in France

January 21, 2016 8:25 am | by Ryan Bushey, Associate Editor | Articles | Comments

The aftermath of a catastrophic clinical trial in France has raised concerns regarding the lack of data shared about the incident.  Read more...


Anti-Hepatitis Harvoni to be Released on Market Soon

January 21, 2016 7:45 am | by Al-Masry Al-Youm, The Egypt Independent | News | Comments

The anti-hepatitis C Harvoni drug, made by US company Gilead, will be available on the Egyptian market within days. Read more...


Baker's Yeast Could Help Create New Anti-Malarial Drugs

January 21, 2016 7:30 am | by St. George's University of London | News | Comments

Malaria is a massive global health burden, with a current WHO estimate of around 600,000 deaths annually. Read more...



You may login with either your assigned username or your e-mail address.
The password field is case sensitive.